Transthyretin Amyloidosis (ATTR)

American College of Cardiology (ACC) 2025

Congress Details

calander29-31 March, 2025 | USA

locationChicago, IL, USA

The materials in this section are intended for UK healthcare professionals and include scientific and educational congress content related to vutrisiran▼. The information contained in these presentations and posters was accurate at the time of presentation. Healthcare professionals should consult the current full Prescribing Information [for the most up-to-date information on indications, dosing, contraindications, warnings, and adverse reactions].

Oral

Congress Materials

Treansthyretin-Amyloidosis
icon Presentation Type
Poster | March 29, 2025
location icon Location
Chicago, IL, USA
icon Title
Maintenance or Improvement of Functional Capacity, Health Status, and Quality of Life with Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy: Data from the HELIOS-B Study
Subgroup-Analysis
icon Presentation Type
Poster | March 29, 2025
location icon Location
Chicago, IL, USA
icon Title
Impact of Baseline Heart Failure Severity on Efficacy of Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy in the HELIOS-B Trial: A Subgroup Analysis
Vutrisiran-in-Transthyretin
icon Presentation Type
Poster | March 29, 2025
location icon Location
Chicago, IL, USA
icon Title
Cardiac Function, Clinical Outcomes and Effect of Vutrisiran in Transthyretin Amyloid Cardiomyopathy - the HELIOS-B Trial

Associated Materials

Transthyretin Amyloidosis (ATTR)

Vutrisiran in Transthyretin Amyloidosis: A Pooled Safety Analysis of HELIOS-A and HELIOS-B

JACC: Advances

Author(s)

Ronald M. Witteles, Pablo Garcia-Pavia, Caroline Morbach, et al

August 2025

Preparation Date
March 2026
Job Code
MB-UK-00167
hfsa-congress-usa-mobile

Transthyretin Amyloidosis (ATTR)

Heart Failure Society of America (HFSA) 2025

26-29 September 2025 USA

View Details
Preparation Date
March 2026
Job Code
MB-UK-00106
eu-attr-italy-mobile

Transthyretin Amyloidosis (ATTR)

European ATTR Amyloidosis Meeting (EU-ATTR) 2025

25-26 September 2025 ITALY

View Details
Preparation Date
March 2026
Job Code
MB-UK-00113
European Society of Cardiology (ESC) 2025 Congress, Spain

Transthyretin Amyloidosis (ATTR)

European Society of Cardiology (ESC) 2025

29 August - 1 September 2025 SPAIN

View Details
Preparation Date
March 2026
Job Code
MB-UK-00118

Transthyretin Amyloidosis (ATTR)

Realising the therapeutic potential of rapid knockdown of transthyretin via RNA interference in transthyretin amyloidosis

Molecular Therapy Nucleic Acids

Author(s)

Martha Grogan, Farooq H. Sheikh, Brett W. Sperry

June 2025

Preparation Date
March 2026
Job Code
MB-UK-00168
Heart Failure Association (HFA) 2025 Congress, Serbia

Transthyretin Amyloidosis (ATTR)

Heart Failure Association (HFA) 2025

17-20 May 2025 Serbia

View Details
Preparation Date
March 2026
Job Code
MB-UK-00127
Preparation Date
March 2026
Job Code
MB-UK-00142